Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Starts Presentation at Dawson James Small Cap Growth Conference
Citius Pharmaceuticals Inc. (NASDAQ: CTXR) is a specialty pharmaceutical company focused on anti-infectives, cancer care and unique prescription products that use innovative, patented or proprietary formulations of previously approved pharmaceutical ingredients. By using previously approved drugs with substantial safety and efficacy data, the company seeks to reduce risks associated with pharmaceutical product development and regulatory requirements. The company develops products that have intellectual property protection and competitive advantages to existing therapeutic approaches. Citius intends to achieve leading market positions by providing therapeutic products that address unmet medical needs. For more information, visit the company's website at www.citiuspharma.com. About NetworkNewsWire NetworkNewsWire (NNW)…